Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence and exhibits lower profile of mammary ERα and ERβ

Maturitas

Volumn 58, Issue 2, 2007, Pages 174-181

  Cherdshewasart, Wichai ^a   Panriansaen, Rattana ^a   Picha, Porntipa ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

7,12 DMBA; Breast cancer; Estrogen receptor; Isoflavonoid; Phytoestrogen; Pueraria mirifica

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ISOFLAVONOID; MONOCLONAL ANTIBODY; PHYTOESTROGEN; PUERARIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE REPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; PHYTOESTROGENS; PHYTOTHERAPY; PLANT TUBERS; PUERARIA; RATS; RATS, SPRAGUE-DAWLEY;

PUERARIA MIRIFICA; RATTUS;

EID: 34948905272     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.08.001     Document Type: Article

References (39)

1. Fitzpatrick L.A. Soy isoflavones: hope or hype?. Maturitas 44 Suppl 1 (2003) S21-S29
2. Lamartiniere C.A., Moore J., Holland M., et al. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208 (1995) 120-123
3. Murrill W.B., Brown N.M., Zhang J.-X., et al. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17 (1996) 1451-1457
4. Hilakivi-Clarke L., Onojafe I., Raygada M., et al. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80 (1999) 1682-1688
5. Lamartiniere C.A., Murrill W.B., Manzolillo P.A., et al. Genistein alters the ontogeny of mammary gland development and protects against chemically induced mammary cancer in rats. Proc Soc Exp Biol Med 217 (1998) 358-364
6. Hilakivi-Clarke L., Cho E., Onojafe I., et al. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6 (1999) 1089-1095
7. Kashemsanta M.L.C., Suvatabhandu K., and Airy Shaw H.K. A new species of Pueraria (Leguminosae) from Thailand, yielding an oestrogenic principle. Kew Bull (1952) 263-266
8. Cain J.C. Miroestrol; an oestrogen from the plant Pueraria mirifica roots. Nature 188 (1960) 774-777
9. Jones H.E.H., and Pope G.S. A method for the isolation of miroestrol from Pueraria mirifica. J Endocrinol 22 (1961) 303-312
10. Jones H.E.M., and Pope G.S. A study of the action of miroestrol and other oestrogens on the reproductive tract of the immature female mouse. J Endocrinol 20 (1960) 229-235
11. Benson G.K., Cowie A.T., and Hosking Z.D. Mammogenic activity of mirostrol. J Endocrinol 21 (1961) 401-409
12. Chansakaow S., Ishikawa T., Seki H., et al. Identification of deoxymiroestrol as the actual rejuvenation principle of "Kwao Keur", Pueraria mirifica. The known miroestrol may be an artifact. J Nat Prod 63 (2000) 173-175
13. Cherdshewasart W., Subtang S., and Dahlan W. Major isoflavonoid contents of the phytoestrogen-rich herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal 43 (2007) 428-434
14. Trisomboon H., Malaivijitnond S., Watanabe G., et al. The estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys. Endocrine 29 (2006) 129-134
15. Trisomboon H., Malaivijitnond S., Cherdshewasart W., et al. The influence of Pueraria mirifica herb containing phytoestrogens on the urinary gonadotropin and estradiol levels in aged menopausal monkeys. Anim Sci J 78 (2007) 378-386
16. Trisomboon H., Malaivijitnond S., Cherdshewasart W., et al. Effect of Pueraria mirifica on the sexual skin coloration of aged menopausal cynomolgus monkeys. J Reprod Dev 52 (2006) 537-542
17. Urasopon N., Hamada Y., Asaoka K., et al. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas 56 (2007) 322-331
18. Dweck A.C. The Pueraria family with special interest in Pueraria mirifica. Personal Care Mag 3 (2003) 7-10
19. Cherdshewasart W., Cheewasopit W., and Picha P. The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. J Ethnopharmacol 93 (2004) 255-260
20. Huggins C.B., Grand L.C., and Brillantes F.P. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (London) 189 (1961) 204-207
21. Chow L.W.C., Cheung M.N.B., Loo W.T.Y., et al. A rat cell line derived from DMBA-induced mammary carcinoma. Life Sci 73 (2003) 27-40
22. Young S., and Hallowes R.C. Tumors of the mammary gland. Pathology of tumors in laboratory animals 1 (1973), IARC, Lyon 31-74
23. Trisomboon H., Malaivijitnond S., Watanabe G., et al. Ovulation block by Pueraria mirifica. Endocrine 26 (2005) 31-39
24. Malaivijitnond S., Kiatthaipipat P., Cherdshewasart W., et al. Different effects of Pueraria mirifica, a herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J Pharm Sci 96 (2004) 428-435
25. Trisomboon H., Malaivijitnond S., Cherdshewasart W., et al. Assessment of urinary gonadotrophin and steroid hormone profiles of female cynomolgus monkeys after treatment with Pueraria mirifica. J Reprod Dev 53 (2007) 395-403
26. Malaivijitnond S., Chansri K., Kijkuokul P., et al. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herbs. J Ethnopharmacol 107 (2006) 354-360
27. Cherdshewasart W., Kitsamai Y., and Malaivijitnond S. Estrogenic activity of the wild Pueraria mirifica evaluated by vaginal cornification assay. J Reprod Dev 53 (2007) 385-393
28. Lazennec G., Bresson D., Lucas A., et al. ERβ Inhibits proliferation and invasion of breast cancer cells. Endocrinology 142 (2001) 4120-4130
29. Park B.W., Kim K.S., Heo M.K., et al. Expression of estrogen receptor-β in normal mammary and tumor tissues: is it protective in breast carcinogenesis?. Breast Cancer Res 80 (2003) 79-85
30. Gallo D., Giacomelli S., Cantelmo F., et al. Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Res Treat 69 (2001) 153-164
31. Gustafsson J.-A. Estrogen receptor beta-a new dimension in estrogen mechanism of action. J Endocrinol 163 (1999) 379-383
32. Morito K., Hirose T., Kinjo J., et al. Interaction of phytoestrogen with estrogen α and β. Biol Pharm Bull 24 (2001) 351-356
33. Lee Y.S., Park J.S., Cho S.D., et al. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica. J Vet Sci 3 (2002) 273-277
34. Xu X., Harris K.S., Wang H.-J., et al. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutri 125 (1995) 2307-2315
35. Hwang C.S., Kwak H.S., Lim H.J., et al. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem 101 (2006) 246-253
36. 2α synthase-like 2 stimulation in bovine endometrium. Prostag Oth Lipid M 78 (2005) 202-217
37. Jeon G.C., Park M.S., Yoon D.Y., et al. Antitumor activity of spinasterol isolated from Pueraria roots. Exp Mol Med 37 (2005) 111-120
38. Muangman V., and Cherdshewasart W. Clinical trail of the phytoestrogen-rich herb, Pueraria mirifica as a crude drug in the treatment of symptoms in menopausal women. Siriraj Hosp Gaz 53 (2001) 300-309
39. Cornwell T., Cohick W., and Raskin I. Dietary phytoestrogens and health. Phytochemistry 65 (2004) 995-1016